Nurix Therapeutics Inc

Nurix CSO’s $0.84 share purchase signals confidence in 2026 milestones; analysts upgrade targets, hinting at potential upside to $30‑$35 per share.

Nurix CFO’s fresh stock purchases signal confidence amid a steep decline—read why insider buying could hint at hidden value and future upside.